|
2025 Conference Publication Isolated respiratory failure as the presenting symptom of muscle-specific kinase (MuSK) myasthenia gravis: case reportElias, Sandra, Mclaughlin, Laurie and Blum, Stefan (2025). Isolated respiratory failure as the presenting symptom of muscle-specific kinase (MuSK) myasthenia gravis: case report. ANZAN Annual Scientific Meeting 2025, Brisbane, QLD Australia, 10-13 June 2025. London, United Kingdom: BMJ Group. doi: 10.1136/bmjno-2025-anzan.38 |
|
2024 Conference Publication Same but different: a rare case of primary cerebral amyloidomaMclaughlin, Laurie, Lefever, Kristen and Blum, Stefan (2024). Same but different: a rare case of primary cerebral amyloidoma. ANZAN Annual Scientific Meeting 2024, Adelaide, SA Australia, 21-24 May 2024. London, United Kingdom: BMJ Group. doi: 10.1136/bmjno-2024-anzan.132 |
|
2023 Conference Publication Novel real world evidence from MSGo, a digital support program for secondary progressive multiple sclerosis patients in Australia using SiponimodHardy, Todd, Aouad, Patrick, Barnett, Michael, Blum, Stefan, Broadley, Simon, Carroll, William, Crimmins, Denis, Griffiths, Dayna, Hodgkinson, Suzanne, Lechner-Scott, Jeannette, Lee, Andrew, Malhotra, Ram, McCombe, Pamela, Parratt, John, Plummer, Christopher, Van der Walt, Anneke, Martel, Kate and Walker, Rob (2023). Novel real world evidence from MSGo, a digital support program for secondary progressive multiple sclerosis patients in Australia using Siponimod. PACTRIMS 2022: 12th Pan-Asian Committee for Treatment and Research in Multiple Sclerosis, Singapore, Singapore, 24-26 November 2022. London, United Kingdom: Sage Publications. |
|
2022 Conference Publication Novel generation of real-world evidence through MSGo, a digital support program supporting the use of siponimod in secondary progressive multiple sclerosis patients in AustraliaHardy, Todd, Aouad, Patrick, Blum, Stefan, Broadley, Simon, Carroll, William, Crimmins, Denis, Griffiths, Dayna, Hodgkinson, Suzanne, Lechner-Scott, Jeanette, Lee, Andrew, Malhotra, Ram, Parratt, John, Plummer, Chris, Walt, Anneke Van der and Walker, Robert (2022). Novel generation of real-world evidence through MSGo, a digital support program supporting the use of siponimod in secondary progressive multiple sclerosis patients in Australia. ANZAN Annual Scientific Meeting 2022, Melbourne, VIC Australia, 10-13 May 2022. London, United Kingdom: BMJ Group. doi: 10.1136/bmjno-2022-anzan.64 |
|
2021 Conference Publication Case Series: Two Cases of First Presentation AQP4-IgG Antibody Positive Neuromyelitis Optica in Patients of Advanced Age as a Possible Paraneoplastic PhenomenonBeer, Reuben, Shahid, Hassan, Brown, Helen and Blum, Stefan (2021). Case Series: Two Cases of First Presentation AQP4-IgG Antibody Positive Neuromyelitis Optica in Patients of Advanced Age as a Possible Paraneoplastic Phenomenon. AAN 73rd Annual Meeting, Online, 17-22 April 2021. Ovid Technologies (Wolters Kluwer Health). doi: 10.1212/wnl.96.15_supplement.2975 |
|
2021 Conference Publication MRI patterns distinguish neuromyelitis optica spectrum disorder from multiple sclerosisClarke, Laura, Arnett, Simon, Bukhari, Wajih, Khalilidehkordi, Elham, Sanchez, Sofia Jimenez, O’Gorman, Cullen, Prain, Kerri, Woodhall, Mark, Silvestrini, Roger, Bundell, Christine, Abernethy, David, Bhuta, Sandeep, Blum, Stefan, Boggild, Mike, Boundy, Karyn, Brew, Bruce, Brownlee, Wallace, Butzkueven, Helmut, Carroll, William, Chen, Celia, Coulthard, Alan, Dale, Russell, Das, Chandi, Fabis-Pedrini, Marzena, Fulcher, David, Gillis, David, Hawke, Simon, Heard, Robert, Henderson, Andrew ... Broadley, Simon (2021). MRI patterns distinguish neuromyelitis optica spectrum disorder from multiple sclerosis. AAN 73rd Annual Meeting, Online, 17-22 April 2021. Philadelphia, PA, United States: Wolters Kluwer. doi: 10.1212/wnl.96.15_supplement.4128 |
|
2020 Conference Publication Specific Psychiatric Features Identify Anti-NMDAR Encephalitis Before Neurological Deterioration (4888)Warren, Nicola, O’Gorman, Cullen, Swayne, Andrew, Siskind, Dan and Blum, Stefan (2020). Specific Psychiatric Features Identify Anti-NMDAR Encephalitis Before Neurological Deterioration (4888). 2020 AAN Science Highlights, Online, 14 April 2020. Philadelphia, PA United States: Wolters Kluwer. doi: 10.1212/wnl.94.15_supplement.4888 |
|
2020 Conference Publication Real world safety of Alemtuzumab in the treatment of Multiple Sclerosis – Australian cohort studyCorbett, Joel, Blum, Stefan, Boggild, Mike, Broadley, Simon and McCombe, Pamela (2020). Real world safety of Alemtuzumab in the treatment of Multiple Sclerosis – Australian cohort study. 2020 AAN Science Highlights, Online, 14 April 2020. Philadelphia, PA United States: Wolters Kluwer. doi: 10.1212/wnl.94.15_supplement.1499 |
|
2020 Conference Publication Generalised Epileptiform Activity in Anti-Glycine Receptor Antibody Autoimmune Limbic EncephalitisBeer, Reuben, Singh, Gaurav, Blum, Stefan and Sabet, Arman (2020). Generalised Epileptiform Activity in Anti-Glycine Receptor Antibody Autoimmune Limbic Encephalitis. 2020 AAN Science Highlights, Online, 14 April 2020. Philadelphia, PA United States: Wolters Kluwer. doi: 10.1212/wnl.94.15_supplement.2836 |
|
2020 Conference Publication Low dose Rituximab in the treatment of myasthenia gravisChan, Fiona, Swayne, Andrew, Gillis, David, Wong, Richard, Walsh, Michael, Henderson, Robert, McCombe, Pamela and Blum, Stefan (2020). Low dose Rituximab in the treatment of myasthenia gravis. 18th Biennial Clinical Neurophysiology Workshop of the Australian and New Zealand Association of Neurologists, Gold Coast, QLD, Australia, 29 September–2 October 2019. E Park, Shannon, Ireland: Elsevier. doi: 10.1016/j.clinph.2019.11.034 |
|
2019 Conference Publication Autoimmune diseases presenting as complex mood disordersScott, E., Leweke, F. M., Jones, C., Dale, R., Brown, D., Blum, S., Scott, J., Harris, A., Cripps, S. and Hickie, I. B. (2019). Autoimmune diseases presenting as complex mood disorders. RANZCP 2019 Congress, Cairns, QLD, Australia, 12-16 May 2019. London, United Kingdom: Sage Publications. doi: 10.1177/0004867419836919 |
|
2018 Conference Publication A case of immune-mediated encephalitis related to daclizumab therapyDevlin, M., Swayne, A., O'Gorman, C., Newman, M., Brown, H., Robertson, T., Airey, C. and Blum, S. (2018). A case of immune-mediated encephalitis related to daclizumab therapy. 34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Berlin, Germany, 10-12 October 2018. London, United Kingdom: Sage Publications. |
|
2018 Conference Publication Psychiatric presentations of autoimmune encephalitisWarren, N., Swayne, A. and Blum, S. (2018). Psychiatric presentations of autoimmune encephalitis. RANZCP 2018 Congress, Auckland, New Zealand, 13 – 17 May 2018. London, United Kingdom: Sage Publications. |
|
2018 Conference Publication Prevalence of anti-neuronal antibodies in patients admitted with first episode of psychosis and their clinical outcomesScott, James, Gillis, David, Ryan, Alex, Hargovan, Hethal and Blum, Stefan (2018). Prevalence of anti-neuronal antibodies in patients admitted with first episode of psychosis and their clinical outcomes. 6th Biennial Schizophrenia International Research Society Conference, Florence, Italy, Apr 04 - 08, 2018. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/schbul/sby014.157 |
|
2018 Conference Publication Prevalence of anti-neuronal antibodies in patients admitted with first episode of psychosis and their clinical outcomesScott, James, Gillis, David, Ryan, Alex, Hargovan, Hethal and Blum, Stefan (2018). Prevalence of anti-neuronal antibodies in patients admitted with first episode of psychosis and their clinical outcomes. 6th Biennial Conference of the Schizophrenia-International-Research-Society (SIRS), Florence, Italy, 04-08 April 2018. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/schbul/sby014 |
|
2017 Conference Publication The many faces of anti-glycine receptor related disease: a case series and literature reviewSwayne, Andrew, Tjoa, Linda, Wong, Richard, Gillis, David, Schweitzer, Daniel, Tsang, Benjamin, McNabb, Andrew, Broadley, Simon and Blum, Stefan (2017). The many faces of anti-glycine receptor related disease: a case series and literature review. Annual Scientific Meeting of the Australian-and-New-Zealand-Association-of-Neurologists (ANZAN), Gold Coast Australia, May 09-12, 2017. London, United Kingdom: BMJ Group. doi: 10.1136/jnnp-2017-316074.15 |
|
2017 Conference Publication A rare case of csf xanthochromia due to severe disc protrusion resulting in froin’s syndromeSingh, Gaurav, Swayne, Andrew, Blum, Stefan, Lehn, Alex, Brown, Helen and O’Gorman, Cullen (2017). A rare case of csf xanthochromia due to severe disc protrusion resulting in froin’s syndrome. ANZAN 2017, Gold Coast, QLD Australia, 9 - 12 May 2017. London, United Kingdom: BMJ. doi: 10.1136/jnnp-2017-316074.74 |
|
2017 Conference Publication Anti-nmda receptor encephalitis complicating hsv encephalitis with demonstrated seroconversionSwayne, Andrew, Brown, Helen, Singh, Gaurav and Blum, Stefan (2017). Anti-nmda receptor encephalitis complicating hsv encephalitis with demonstrated seroconversion. ANZAN 2017, Gold Coast, QLD, Australia, 9 - 12 May 2017. London, United Kingdom: BMJ. doi: 10.1136/jnnp-2017-316074.82 |
|
2017 Conference Publication Symptomatic and objective clinical improvement in progressive multiple sclerosis patients treated with autologous Epstein-Barr virus-specific T cell therapy: interim results of a phase I trialPender, Michael, Csurhes, Peter, Smith, Corey, Douglas, Nanette, Neller, Michelle, Beagley, Leone, Rehan, Sweera, Hopkins, Tracey, Thompson, Kate, Blum, Stefan, Green, Kerryn, Ioannides, Zara, Coulthard, Alan, Hooper, Kaye, Burrows, Scott and Khanna, Rajiv (2017). Symptomatic and objective clinical improvement in progressive multiple sclerosis patients treated with autologous Epstein-Barr virus-specific T cell therapy: interim results of a phase I trial. 69th Annual Meeting of the American Academy of Neurology (AAN), Boston, Massachusetts, 22-28 April 2017. Philadelphia, PA, United States: Lippincott Williams & Wilkins. |
|
2017 Conference Publication Safety and clinical improvement in a phase I trial of autologous Epstein-Barr virus-specific T-cell therapy in patients with progressive multiple sclerosisPender, M. P., Csurhes, P. A., Smith, C., Douglas, N. L., Neller, M. A., Beagley, L., Rehan, S., Hopkins, T. J., Thompson, K. M., Blum, S., Green, K. A., Ioannides, Z. A., Coulthard, A., Hooper, K. D., Burrows, S. R. and Khanna, R. (2017). Safety and clinical improvement in a phase I trial of autologous Epstein-Barr virus-specific T-cell therapy in patients with progressive multiple sclerosis. 7th Joint European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS), Paris, France, 25-28 October 2017. London, United Kingdom: Sage Publications. |
